Peripheral resistance artery blood flow in subjects with abnormal glucose tolerance is improved following enhanced external counterpulsation therapy.
Enhanced external counterpulsation (EECP) improves resistance artery function in coronary artery disease patients. However, whether EECP elicits similar effects in persons with abnormal glucose tolerance (AGT) is unknown. Here we provide novel evidence that EECP significantly improves resistance arterial function in the forearm of persons with AGT, whereas the calf only approached significance (P ≤ 0.10). These improvements were coincident with greater glycemic control, providing further insight into the potential mechanisms of EECP-mediated alterations in glycemia.
a Department of Biomedical Sciences, Quinnipiac University, Hamden, CT 06518, USA.
Jeffrey S
JS
Martin
Darren T
DT
Beck
Randy W
RW
Braith
D003324:Coronary Artery Disease / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy; D015908:Counterpulsation / Q000379:methods; D018149:Glucose Intolerance / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012039:Regional Blood Flow / Q000502:physiology*; D014655:Vascular Resistance / Q000502:physiology*